Recent research indicates that Semaglutide GLP-1 may be more successful for weight loss in persons with a high Body Mass Index (BMI)
The compound has become one of the most recognised peptides within modern research literature due to its defined molecular structure, reproducible analytical profile and extensive use in experimental peptide investigations
Future GLP-2 trials in IBD should stratify patients by disease phenotype (mucosal UC, inflammatory CD, stricturing CD) and incorporate serial cross-sectional imaging to monitor for stricture progression, given the mechanistic link between GLP-2R signaling through subepithelial myofibroblasts and intestinal fibrogenesis
Provide adequate cooling in high-power applications
Now heres the funny bit The MHRA in responding to our petition stated: Vitamin B12 could not legally be classified as a medicine that can be made available for sale without prescription in pharmacies because it is an injection and because the condition it is licensed to treat, pernicious anaemia, needs a clinician to diagnose it, and monitor its treatment (see point IV above)
Targeting ferroptosis as a vulnerability in cancer